Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | orlistat | 3034010 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | orlistat | 3034010 | drug-path |
Proteasome | R-HSA-68819 | map03050 | orlistat | 3034010 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | fluorocurarine | 21586665 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | fluorocurarine | 21586665 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | fluorocurarine | 21586665 | drug-path |
Glioma | Q9NZM4 | map05214 | moxonidine | 4810 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | moxonidine | 4810 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | moxonidine | 4810 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | moxonidine | 4810 | drug-path |
Shigellosis | 0 | map05131 | moxonidine | 4810 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | moxonidine | 4810 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | moxonidine | 4810 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | moxonidine | 4810 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | moxonidine | 4810 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | moxonidine | 4810 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | moxonidine | 4810 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | moxonidine | 4810 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | moxonidine | 4810 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | moxonidine | 4810 | drug-path |